TrimRX
US$ 24.45
glp-1 gastroparesis Diabetic Ozempic Gastroparesis Lawsuits | GLP-1
Description
A Paradigm Shift in Obesity-Linked Insulin Resistance
Many patients switch to achieve better blood sugar control or greater weight loss
It really goes against what we're trying to do in the field of obesity and treat chronic illness, Levy adds
10.2337/dc19-1745 28 GersteinH
A May 2024 analysis based on nationally representative commercial data found that people living in underserved regions were less likely to complete 12 weeks of treatment (the minimal time period associated with clinically meaningful weight loss) than those living in more well-resourced areas
